Fintech PR
NESPRESSO WILL INVEST 20 MILLION USD IN DRC TO SUPPORT THE COFFEE GROWING COMMUNITY AND THE REVIVAL OF THE SPECIALTY COFFEE
Focusing on an increased sourcing of high-quality coffee, as well as implementing regenerative practices, gender equality programs and projects to increase access to healthcare and clean water.
VEVEY, Switzerland, March 27, 2024 /PRNewswire/ — Nespresso aims to continue to support the local community and economy by investing 20 million USD spent across coffee purchases, price premiums and technical assistance, by 2026 in the Democratic Republic of Congo (DRC), helping to give coffee farmers access to the global markets. The ambition is also to help support fund raising of an additional 20 million USD to support the coffee growing communities in Kivu. This initiative is part of the unique Nespresso Reviving Origins program, founded 10 years ago, aiming to restore coffee agriculture in regions where it is under threat.
In 1980, coffee was the second most important export for DRC and ranked among the world’s finest but declined in the early 2000s due to years of instability that had a devastating impact on the industry.
Since the launch of the Nespresso Reviving Origins program in DRC in 2020 it has enabled the production of the exquisite coffees from the Lake Kivu region, where the once-thriving coffee farming community has been, and still is, devastated by decades of political and economic instability, that continue to rise today.
Guillaume Le Cunff, CEO Nespresso says, “Kivu has the potential to be among the world’s great coffee regions but has faced extremely challenging conditions in recent years. Through our Reviving Origins program, we work closely with Congolese farmers, and we have joined forces with partners including, Eastern Congo Initiative (ECI)/ASILI, TechnoServe, the U.S. Agency for International Development (USAID), The Global Environment Facility (GEF), Clarmondial, International Union for Conservation of Nature (IUCN), and Virunga Coffee to restore and revitalize Kivu as a leading source of high-quality, exceptional Arabica coffee. In the context of escalating violence in eastern DRC where access to water is becoming insufficient, water-borne illnesses have resurfaced, and daily life is under significant upheaval, it is even more critical to help build community resilience, access to health care and clean water as well as support farmer livelihoods by continuing to give them access to the global market and empowering them in their agricultural transition.”
With the continued investment of 20 million USD in the region, as well as with the ambition to support to raise funds of another 20 million USD, Nespresso aims to continue the work to back the revival of the DRC coffee sector.
“Nespresso’s deep commitment to Kivu is creating lasting change in communities across the region. In our work together equipping farmers with the knowledge and market connections they need to thrive, we have seen the transformative impact that coffee can have in Kivu,” said TechnoServe CEO William Warshauer. “We believe this initiative will help inspire other companies to invest there.”
Abraham Leno, Executive director of ECI says, “Since we started working together, we have built a large health center and an entire water system in the farming community of Minova. Today, our medical team provides safe deliveries and gets hundreds of kids ready for school. More than 22,000 people from the local community have access to clean water, and as displacement soars, we are a primary source of water for thousands of families fleeing violence. With the continued support from Nespresso, we aim to continue this work, expanding dignified and sustainable access to clean water and healthcare.”
Nespresso’s unique sustainable green coffee sourcing program, the Nespresso AAA Sustainable Quality™ Program, provides the foundation for the work in the Reviving Origins program. For 20 years, the AAA Program has built strong relationships with coffee farmers across the world to protect the nature and life in landscapes where coffee is grown and to strengthen communities’ resilience. When supporting to rebuilding and reviving the coffee sector in DRC, Nespresso will further deploy the AAA Program and support the farmers in implementing regenerative practices such as crop diversification, stumping, soil health improvement, agroforestry etc. Via the AAA Program Nespresso will also implement a biodiversity tracking tool using DRCs unique birdlife.
Other important projects within the AAA Program in DRC are gender equality trainings. By advancing gender equality this can have a significant impact on coffee quality and productivity and the livelihoods of coffee farming communities. To date concrete examples of actions to reduce gender disparities and increase women´s empowerment includes the increase of women agronomists, currently in DRC 42% of the agronomists are female, trainings for farmers that increase women’s empowerment, such as financial literacy, household nutrition, “Safe Spaces” gender training and women’s leadership.
Finally, since 2020 Nespresso have been collaborating with an impact digital start-up to verify and trace the coffee by harnessing the power technology. The platform will automatically verify that farmers receive the right payment (including the Nespresso AAA Sustainable Quality™ Program premium) for the high-quality coffee they produce.
About Nestlé Nespresso SA
Nestlé Nespresso SA is the pioneer and reference for highest-quality portioned coffee. The company works with more than 150,000 farmers in 18 countries through its AAA Sustainable Quality™ Program to embed sustainability practices on farms and the surrounding landscapes. Launched in 2003 in collaboration with the NGO Rainforest Alliance, the program helps to improve the yield and quality of harvests, ensuring a sustainable supply of high-quality coffee and improving livelihoods of farmers and their communities.
In 2022, Nespresso achieved B Corp™ certification – joining an international movement of over 7,900 purpose-led businesses that meet B Corp’s high standards of social and environmental responsibility and transparency.
Headquartered in Vevey, Switzerland, Nespresso operates in 93 markets and has 14’000 employees. In 2023, it operated a global retail network of 791 boutiques. For more information, visit the Nespresso corporate website: www.nestle-nespresso.com.
Photo – https://mma.prnewswire.com/media/2368903/Nestle_Nespresso_SA.jpg
View original content:https://www.prnewswire.co.uk/news-releases/nespresso-will-invest-20-million-usd-in-drc-to-support-the-coffee-growing-community-and-the-revival-of-the-specialty-coffee-302096296.html
STOCKHOLM, April 5, 2024 /PRNewswire/ — EQT AB’s Q1 Announcement 2024 will be published on Thursday 18 April 2024 at approximately 07:30 CEST. EQT will host a conference call at 08:30 CEST to present the report, followed by a Q&A session.
The presentation and a video link for the webcast will be available here from the time of the publication of the Q1 Announcement.
To participate by phone and ask questions during the Q&A, please register here in advance. Upon registration, you will receive your personal dial-in details.
The webcast can be followed live here and a recording will be available afterwards.
Information on EQT AB’s financial reporting
The EQT AB Group has a long-term business model founded on a promise to its fund investors to invest capital, drive value creation and create consistent attractive returns over a 5 to 10-year horizon. The Group’s financial model is primarily affected by the size of its fee-generating assets under management, the performance of the EQT funds and its ability to recruit and retain top talent.
The Group operates in a market driven by long-term trends and thus believes quarterly financial statements are less relevant for investors. However, in order to provide the market with relevant and suitable information about the Group’s development, EQT publishes quarterly announcements with key operating numbers that are relevant for the business performance (taking Nasdaq’s guidance note for preparing interim management statements into consideration). In addition, a half-year report and a year-end report including financial statements and further information relevant for investors is published. Finally, EQT also publishes an annual report including sustainability reporting.
Contact
Olof Svensson, Head of Shareholder Relations, +46 72 989 09 15
EQT Shareholder Relations, [email protected]
Rickard Buch, Head of Corporate Communications, +46 72 989 09 11
EQT Press Office, [email protected], +46 8 506 55 334
This information was brought to you by Cision http://news.cision.com
https://news.cision.com/eqt/r/invitation-to-presentation-of-eqt-ab-s-q1-announcement-2024,c3956826
The following files are available for download:
|
Invitation to presentation of EQT AB’s Q1 Announcement 2024 |
|
|
EQT AB Group |
View original content:https://www.prnewswire.co.uk/news-releases/invitation-to-presentation-of-eqt-abs-q1-announcement-2024-302109147.html
- Kia drives forward transformation into ‘Sustainable Mobility Solutions Provider’
- Roadmap enables Kia to proactively respond to uncertainties in mobility industry landscape, including changes in EV market
- Company to expand EV line-up with more models; enhance HEV line-up to manage fluctuation in EV demand
- Goal to sell 1.6 million EVs annually in 2030, introducing 15 models
- PBV to play a key role in Kia’s growth, targeting 250,000 PBV sales annually by 2030 with PV5 and PV7 models
- Kia to invest KRW 38 trillion by 2028, including KRW 15 trillion for future business
- 2024 business guidance : KRW 101 tln in revenue with KRW 12 tln in operating profit; operating profit margin of 11.9% on sales of 3.2 million units globally
- CEO reaffirms Kia’s commitment to ESG management
SEOUL, South Korea, April 5, 2024 /PRNewswire/ — Kia Corporation (Kia) today shared an update on its future strategies and financial targets at its CEO Investor Day in Seoul, Korea.
Based on its innovative achievements in the years since the announcement of mid-to-long-term business initiatives, Kia is focusing on updating its 2030 strategy announced last year and further strengthening its business strategy in response to uncertainties across the global mobility industry landscape.
During the event, Kia updated its mid-to-long-term business strategy with a focus on electrification, and its PBV business. Kia reiterated its 2030 annual sales target of 4.3 million units, including 1.6 million units of electric vehicles (EVs). The 2030 4.3 million annual sales target is 34.4 percent higher than the brand’s 2024 annual goal of 3.2 million units.
The company also plans to become a leading EV brand by selling a higher percentage of electrified models among its total sales, including hybrid electric vehicles (HEV), plug-in hybrid (PHEV), and battery EVs, projecting electrified model sales of 2.48 million units annually or 58 percent of Kia’s total sales in 2030.
“Following our successful brand relaunch in 2021, Kia is enhancing its global business strategy to further the establishment of an innovative EV line-up and accelerate the company’s transition to a sustainable mobility solutions provider,” said Ho Sung Song, President and CEO of Kia. “By responding effectively to changes in the mobility market and efficiently implementing mid-to-long-term strategies, Kia is strengthening its brand commitment to the wellbeing of customers, communities, the global society, and the environment.”
Photo – https://mma.prnewswire.com/media/2380039/Photo_1__2024_CEO_Investor_Day.jpg
PDF – https://mma.prnewswire.com/media/2380040/Press_Release__2024_Kia_CEO_Investor_Day_240405.pdf
View original content to download multimedia:https://www.prnewswire.co.uk/news-releases/kia-presents-roadmap-to-lead-global-electrification-era-through-evs-hevs-and-pbvs-302109142.html
VANCOUVER, BC, April 4, 2024 /PRNewswire/ — BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) (OTCQB: BVAXF) (the “Company“) is providing this bi-weekly update on the status of the management cease trade order granted on February 29, 2024 (the “MCTO“), by its principal regulator, the Ontario Securities Commission (the “OSC“), under National Policy 12-203 – Management Cease Trade Orders (“NP 12-203“), following the Company’s announcement on February 21, 2024 (the “Default Announcement“), that it was unable to file its audited annual financial statements for the year ended October 31, 2023, its management’s discussion and analysis of financial statements for the year ended October 31, 2023, its annual information form for the year ended October 31, 2023, and related filings (collectively, the “Required Annual Filings“). Under National Instrument 51-102, the Required Annual Filings were required to be made no later than February 28, 2024.
As a result of the delay in filing the Required Annual Filings, the Company was unable to file its interim financial statements for the three months ended January 31, 2024, its management’s discussion and analysis of financial statements for the three months ended January 31, 2024, and related filings (collectively, the “Required Interim Filings“). Under National Instrument 51-102, the Required Interim Filings were required to be made no later than April 1, 2024.
The Company anticipates filing the Required Annual Filings by April 30, 2024. The auditor of the Company requires additional time to complete its audit of the Company, including the Company’s recent acquisition of all intellectual property, immunotherapeutics platform technologies, and clinical stage assets of the former IMV Inc. that closed on February 16, 2024. In addition, the Company anticipates filing the Required Interim Filings immediately after the filing of the Required Annual Filings.
Except as herein disclosed, there are no material changes to the information contained in the Default Announcement. In addition, (i) the Company is satisfying and confirms that it intends to continue to satisfy the provisions of the alternative information guidelines under NP 12-203 and issue bi-weekly default status reports for so long as the delay in filing the Required Annual Filings and/or Required Interim Filings is continuing, each of which will be issued in the form of a press release; (ii) the Company does not have any information at this time regarding any anticipated specified default subsequent to the default in filing the Required Annual Filings and Required Interim Filings; (iii) the Company is not subject to any insolvency proceedings; and (iv) there is no material information concerning the affairs of the Company that has not been generally disclosed.
About BioVaxys Technology Corp.
BioVaxys Technology Corp. (www.biovaxys.com), a biopharmaceuticals company registered in British Columbia, Canada, is a clinical-stage biopharmaceutical company dedicated to improving patient lives with novel immunotherapies based on the DPX™ immune-educating technology platform and it’s HapTenix© ‘neoantigen’ tumor cell construct platform, for treating cancers, infectious disease, antigen desensitization, and other immunological fields. The Company’s clinical stage pipeline includes maveropepimut-S which is in Phase II clinical development for advanced Relapsed-Refractory Diffuse Large B Cell Lymphoma (DLBCL) and platinum resistant ovarian cancer, and BVX-0918, a personalized immunotherapeutic vaccine using it proprietary HapTenix© ‘neoantigen’ tumor cell construct platform which is soon to enter Phase I in Spain for treating refractive late-stage ovarian cancer. The Company is also capitalizing on its tumor immunology know-how and creation of a unique library of T-lymphocytes & other datasets post-vaccination with its personalized immunotherapeutic vaccines to utilize predictive algorithms and other technologies to identify new targetable tumor antigens. BioVaxys common shares are listed on the CSE under the stock symbol “BIOV” and trade on the Frankfurt Bourse (FRA: 5LB) and in the US (OTCQB: BVAXF). For more information, visit www.biovaxys.com and connect with us on X and LinkedIn.
ON BEHALF OF THE BOARD
Signed “James Passin“
James Passin, Chief Executive Officer
Phone: +1 646 452 7054
Logo – https://mma.prnewswire.com/media/1430981/BIOVAXYS_Logo.jpg
View original content:https://www.prnewswire.co.uk/news-releases/biovaxys-technology-corp-provides-bi-weekly-mcto-status-update-302108920.html
-
Latest News4 days ago
TerraPay Continues to Attract Top Industry Talent, Names Hassan Chatila as Vice President and Global Head of Network
-
Latest News4 days ago
The General Assembly of Siniora Food Industries Company approved the distribution of cash dividends amounting to JD 4.2 million representing 15% of its paid-in capital, and stock dividends amounting to 2,147,059 shares
-
Latest News4 days ago
Top 10 Sessions You Can’t Miss at MARE BALTICUM Gaming & TECH Summit 2024 (Tallinn, Estonia, 4-5 June)
-
Latest News5 days ago
Halal Economy Leadership Forum 2024 Riyadh: IsDB, HPDC and HDC’s Collaboration to Spearhead Innovation for Global Halal Industry
-
Latest News5 days ago
IRIS Business Services Introduces “IRIS Myeinvois” SaaS Platform for Seamless e-Invoice Compliance in Malaysia
-
Latest News4 days ago
Tiger Brokers (HK) officially launches virtual asset trading services, leading the way in Hong Kong’s online brokerage industry
-
Latest News4 days ago
ICEYE Announces API That Allows Customers to Directly Task World’s Largest SAR Satellite Constellation
-
Latest News6 days ago
QNB Group appoints prominent actor Ahmed Helmy as Brand Ambassador